Basking Biosciences appoints former Pulmocide chief medical officer Lance Berman

Basking Biosciences announced the addition of Lance Berman as its new chief medical officer. The appointment was highlighted in a recent industry column that tracks personnel changes.

Berman comes to Basking after serving as chief medical officer at Pulmocide, where he oversaw the company's medical strategy. His experience in respiratory therapeutics is expected to bolster Basking’s pipeline development.

The news was part of a regular feature that lists recent hires, promotions and departures across the pharmaceutical sector, underscoring the ongoing talent mobility within the industry.